Atossa Therapeutics Inc (NASDAQ:ATOS)
| 0.8643 BATS BZX Real-Time Price As of Sep 28 |  0.00 / 0.00%Today’s Change | 0.80 Today|||52-Week Range 3.35 | -45.98% Year-to-Date |
Latest ATOS News | Press Releases
No recent news for Atossa Therapeutics Inc.
Today’s Trading
| Previous close | 0.86 |
| Today’s open | 0.83 |
| Day’s range | 0.83 - 0.86 |
| Volume | 3,268 |
| Average volume (3 months) | 1,074,256 |
| Market cap | $102.6M |
Data as of 3:59pm ET, 09/28/2022
Growth & Valuation
| Earnings growth (last year) | +91.08% |
| Earnings growth (this year) | -11.11% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -- |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.75 |
Competitors
Data as of 4:00pm ET, 09/28/2022
Financials
| Next reporting date | November 15, 2022 |
| EPS forecast (this quarter) | -$0.06 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$20.6M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Seattle, Washington |
Forecasts
